Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Urate Oxidase for the Prevention and Treatment of Tumour Lysis Syndrome in Children With Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436310/all/images/closex.png. Accessed 27 April 2024.
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436310/all/images/closex.png. Accessed April 27, 2024.
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436310/all/images/closex.png
Urate Oxidase for the Prevention and Treatment of Tumour Lysis Syndrome in Children With Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436310/all/images/closex.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer
ID - 436310
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436310/all/images/closex.png
DB - Evidence Central
DP - Unbound Medicine
ER -